Direkt zum Inhalt
Merck
Alle Fotos(2)

Dokumente

719846

Sigma-Aldrich

Resomer® X 206 S, Poly(dioxanon)

Synonym(e):

RESOMER® X 206 S, PDS

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(2)

About This Item

Lineare Formel:
(C4H6O3)n
CAS-Nummer:
29223-92-5
MDL-Nummer:
MFCD00868119
UNSPSC-Code:
12162002
NACRES:
NA.23

Form

solid

Zeitrahmen für den Abbau

<6 months

Inhärente Viskosität

1.5-2.2 dL/g, 0.1 % (w/v) in hexafluoroisopropanol(30 °C, Ubbelohde) (size 0c glass capillary viscometer)

Übergangstemp.

Tg −10-−5 °C
Tm 110-115 °C

Lagertemp.

−20°C

InChI

1S/C4H6O3/c5-4-3-6-1-2-7-4/h1-3H2

InChIKey

VPVXHAANQNHFSF-UHFFFAOYSA-N

Verwandte Kategorien

Allgemeine Beschreibung

Polydioxanone (PDO) is a colorless, crystalline, highly flexible and resorbable biopolymer.

Anwendung

PDO is widely used as a monofilament wound suture. PDO/elastin-based blends prepared by electrospinning may be used as cardiovascular grafts.

Rechtliche Hinweise

Product of Evonik
RESOMER is a registered trademark of Evonik Rohm GmbH

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Jean W M Gardeniers et al.
Clinical orthopaedics and related research, 471(7), 2225-2230 (2013-03-06)
Surgical treatment options for sternoclavicular joint luxations described in the literature are numerous, although all have limitations. Therefore, there is no favorable surgical treatment for sternoclavicular luxations when nonoperative treatment has failed. We developed the polydioxanone (PDS) envelope plasty, a
Mitchell D Eggers et al.
Journal of vascular and interventional radiology : JVIR, 23(8), 1023-1030 (2012-07-31)
To test absorbable materials as a prelude to development of an absorbable vena cava filter for the prevention of pulmonary embolism (PE). Three absorbing polymer candidates, poliglecaprone (Monocryl; sizes 4-0 and 1), polyglactin (Vicryl; sizes 4-0 and 1), and polydioxanone
O Hakimi et al.
European cells & materials, 24, 344-357 (2012-10-24)
Rotator cuff tendon pathology is thought to account for 30-70 % of all shoulder pain. For cases that have failed conservative treatment, surgical re-attachment of the tendon to the bone with a non-absorbable suture is a common option. However, the failure
Falk Birkenfeld et al.
The Journal of craniofacial surgery, 23(4), 953-956 (2012-07-11)
The objectives of this study were (i) to evaluate different fracture mechanisms for orbital floor fractures and (ii) to measure forces and displacement of intraorbital tissue after orbital traumata to predict the necessity of strength for reconstruction materials. Six fresh
Christian Conderman et al.
The Laryngoscope, 123(2), 339-343 (2012-09-12)
This study attempts to characterize the biomechanical properties of a PDS-cartilage composite graft for use in septorhinoplasty. Experimental Study. This study used a PDS analog, porcine cartilage cut to 1 × 5 × 20 mm, and a mechanical testing platform
Alle zugehörigen Dokumente anzeigen

Artikel

Segmented Copolymers of p-dioxanone, Glycolide, and Lactide: Advantages and Applications in Biomedical

Main features of p-dioxanone, glycolide and lactide based copolymers

RESOMER® - Biodegradable Polymers for Sutures, Medical Devices, Drug Delivery Systems and Tissue Engineering

Interest in utilizing biodegradable polymers for biomedical applications has grown since the 1960s.

Biodegradable Polyester Nanoparticle Formation

AliAliphatic polyesters, including polylactide and polyglycolide, are biodegradable polymers widely used in medical applications.

Therapeutic Nanoparticles Harness Myeloid Cells for Brain Tumor-Targeted Delivery and Immunomodulation

Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.

Alle anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.